Metraipolis › archive › dc_c1951e8c2952

Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care — Europe PMC PMID:41150061

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41150061
DOI: 10.3390/vetsci12100921
License (as archived): solo-consultazione
Archived: 2026-11-09T19:48:44.730Z
SHA-256 of the archived text: 4353d43262d8b203750f251f7ee02e2c1c799ee07814fc5e7731622b6464aade
Stable URL of this page: https://metraipolis.com/documento/dc_c1951e8c2952

How to cite

Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care — Europe PMC PMID:41150061 — Europe PMC (en), https://europepmc.org/article/MED/41150061 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c1951e8c2952 (Metraipolis archive dc_c1951e8c2952, sha256 4353d43262d8b203750f251f7ee02e2c1c799ee07814fc5e7731622b6464aade)

BibTeX

@misc{dcc1951e8c2952,
  title = {Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care — Europe PMC PMID:41150061},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41150061},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c1951e8c2952; sha256 4353d43262d8b203750f251f7ee02e2c1c799ee07814fc5e7731622b6464aade},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41150061. Agents can read the archived copy with the MCP tool read_document.